Cancer Checkup: Advancements in Screening

Join researchers from the Early Cancer Detection Program at UCalgary and Tom Baker Cancer Centre to learn more about new cancer detection technologies that’ll save more lives.

You might also be interested in:

Beyond the Headlines: Understanding the Opioid Crisis

Beyond the Headlines: Understanding the Opioid Crisis

Did you know opioid overdoses results in roughly three deaths in Alberta every day? Come learn what’s being done on this issue on Saturday, Sept. 23.

Learn more

What’s the Big Idea? Enterprising Calgarians' Innovations

What’s the Big Idea? Enterprising Calgarians' Innovations

Hear some of UCalgary’s most entrepreneurial alumni break down how great innovations permeate and impact our way of life. Saturday, Sept. 23.

Learn more

See all Alumni Weekend sessions

See all Alumni Weekend sessions

Alumni Weekend has something for everyone. Check out all of your opportunities to learn, connect and play.

Learn more

Learn more

Early cancer detection — including identifying a predisposition to cancer, detecting the presence of early stage or recurrent disease, and monitoring of cancer treatment — is a major health need that is also becoming a provincial and international priority. While cancer screening has improved outcomes for several cancers, there remains a large unmet need for less-invasive, easier-to-use and less-expensive detection tests that can identify cancerous changes much earlier than is currently possible. That’s about to change thanks, in large part, to the Early Cancer Detection Program being launched at UCalgary and Tom Baker Cancer Centre.

 

Join researchers from the Early Cancer Detection Program — a multidisciplinary and international collaborative effort — to learn more about the new cancer-detection technologies under development and discover how these rapid advancements will save more lives.

Speakers

 Dr. Oliver Bathe, MD’90

Dr. Oliver Bathe, MD’90

Alumnus Dr. Oliver Bathe, MD’90, is a UCalgary surgery and oncology professor, as well as a surgical oncologist with a special interest in hepatobiliary, pancreatic and gastrointestinal tumours. He is leading an interdisciplinary team to develop a blood test that will change the way colorectal cancer is diagnosed. Not only will the blood test detect this form of cancer, it will also uncover pre-cancerous colon polyps. This sensitive, convenient and inexpensive test is poised to replace the stool tests currently used to screen for colorectal cancer.

Kristina Rinker

Kristina Rinker

Kristina Rinker is the director of the Centre for Bioengineering Research and Education and an associate professor in the Department of Chemical and Petroleum Engineering (Schulich School of Engineering) and Department of Physiology and Pharmacology (Cumming School of Medicine). Her research is highly collaborative, both locally and internationally, and focuses on recreating healthy and diseased tissues in the lab for discovery and technology development of new drugs and diagnostics. Her team’s technology will not only spare some women the need to undergo a breast tissue biopsy, but will also provide a means to detect breast cancer in younger patients and at an earlier stage.

Dr. Don Morriss

Dr. Don Morris

Dr. Don Morris is an associate professor of oncology and a medical oncologist at the Tom Baker Cancer Centre and University of Calgary. He’s one of the founders of the Translational Laboratories at Tom Baker and has been instrumental in advancing clinical testing for drugs and diagnostics. He has a special interest in the development of novel cancer therapeutics, oncolytic viruses, and immunotherapeutics for the diagnosis and treatment of lung cancer.